Glenmark Pharma Ltd.

BSE: 532296 | NSE: GLENMARK |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE935A01035 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Glenmark Pharm Glenmark Pharma Ltd. | BSE 2039.40 9.80 (0.48%) | NSE 2038.20 8.40 (0.41%) | Trade | Add

BSE Live

Dec 31, 10:58

2039.40 9.80 (0.48%)

Volume

AVERAGE VOLUME

5-Day

22,636

10-Day

16,547

30-Day

18,797

1,987

Prev. Close

2029.60
Open Price

2030.10

Bid Price (Qty.)
2037.25 (2)
Offer Price (Qty.)
2038.50 (19)

NSE Live

Dec 31, 10:58

2038.20 8.40 (0.41%)

Volume

AVERAGE VOLUME

5-Day

952,149

10-Day

713,554

30-Day

799,303

83,430

Prev. Close

2029.80
Open Price

2030.90

Bid Price (Qty.)
2038.10 (53)
Offer Price (Qty.)
2038.80 (14)

Financials

Print/Copy to Excel : Go

Key Financial Ratios of Glenmark Pharma (in Rs. Cr.)	Mar 15	Mar 14	Mar 13	Mar 12	Mar 11
Per Share Ratios
Basic EPS (Rs.)	17.52	20.01	22.71	17.03	16.78
Diluted EPS (Rs.)	17.52	20.00	22.69	17.01	16.76
Cash EPS (Rs.)	27.10	28.11	27.69	20.78	20.44
Book Value [ExclRevalReserve]/Share (Rs.)	110.58	110.48	102.91	61.16	47.80
Book Value [InclRevalReserve]/Share (Rs.)	110.58	110.48	102.91	61.16	47.80
Revenue from Operations/Share (Rs.)	244.36	221.41	185.06	148.62	109.12
PBDIT/Share (Rs.)	38.44	40.40	37.53	26.75	27.11
PBIT/Share (Rs.)	28.86	32.40	32.84	23.13	23.61
PBT/Share (Rs.)	21.90	25.69	27.09	18.04	17.82
Net Profit/Share (Rs.)	17.52	20.12	23.00	17.16	16.94
NP After MI And SOA / Share (Rs.)	17.52	20.12	23.00	17.02	16.77
Profitability Ratios
PBDIT Margin (%)	15.73	18.24	20.27	17.99	24.84
PBIT Margin (%)	11.81	14.63	17.74	15.56	21.63
PBT Margin (%)	8.96	11.60	14.63	12.13	16.32
Net Profit Margin (%)	7.16	9.08	12.42	11.54	15.52
NP After MI And SOA Margin (%)	7.16	9.08	12.42	11.44	15.36
Return on Networth/Equity (%)	15.84	18.28	22.54	28.25	35.82
Return on Capital Employed (%)	7.95	9.59	12.48	11.56	15.96
Return on Assets (%)	4.90	6.31	8.68	7.82	8.89
Total Debt/Equity (X)	0.97	1.10	0.83	1.23	1.66
Asset Turnover Ratio (%)	68.43	69.55	69.89	68.33	57.85
Liquidity Ratios
Current Ratio (X)	1.43	1.61	1.72	1.55	1.15
Quick Ratio (X)	1.09	1.30	1.33	1.14	0.79
Inventory Turnover Ratio (X)	5.22	6.44	5.94	5.10	3.65
Dividend Payout Ratio (NP) (%)	0.00	0.00	0.00	2.73	2.78
Dividend Payout Ratio (CP) (%)	0.00	0.00	0.00	2.25	2.30
Earnings Retention Ratio (%)	0.00	0.00	0.00	97.27	97.22
Cash Earnings Retention Ratio (%)	0.00	0.00	0.00	97.75	97.70
Coverage Ratios
Interest Coverage Ratios (%)	4.15	4.83	5.71	4.55	4.08
Interest Coverage Ratios (Post Tax) (%)	4.15	4.83	5.71	4.55	4.08
Valuation Ratios
Enterprise Value (Cr.)	23,478.62	17,827.92	14,233.33	10,022.43	9,590.22
EV/Net Operating Revenue (X)	3.54	2.97	2.84	2.49	3.25
EV/EBITDA (X)	22.51	16.27	14.00	13.85	13.09
MarketCap/Net Operating Revenue (X)	3.22	2.56	2.50	2.07	2.60
Retention Ratios (%)	0.00	0.00	0.00	97.26	97.21
Price/BV (X)	7.11	5.14	4.53	5.11	6.06
Price/Net Operating Revenue	3.22	2.56	2.50	2.07	2.60
Earnings Yield	0.02	0.04	0.05	0.06	0.06